Global Safety and Efficacy Study of Crinecerfont for the Treatment of Classic Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency (21-OHD) in Pediatric Participants SRL

Need to get in touch with us?

medinfo@neurocrine.com
1-877-641-3461